{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+fluticasone&page=2", "query": { "intervention": "Placebo fluticasone", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 170, "total_pages": 17, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+fluticasone&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+fluticasone&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-30T08:03:20.523Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00266578", "title": "A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Eosinophilic Esophagitis" ], "interventions": [ { "name": "Fluticasone Propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Marc Rothenberg", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "3 Years to 30 Years" }, "enrollment_count": 30, "start_date": "2002-10", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2013-04-11", "last_synced_at": "2026-09-30T08:03:20.523Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00266578" }, { "nct_id": "NCT02135718", "title": "ELLIPTA™ vs. MDI Inhaler Preference Study, in Adult Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma" ], "interventions": [ { "name": "ELLIPTA inhaler", "type": "DEVICE" }, { "name": "Placebo Inhalation Aerosol (MDI)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 288, "start_date": "2014-06", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2016-06-08", "last_synced_at": "2026-09-30T08:03:20.523Z", "location_count": 15, "location_summary": "Huntington Beach, California • Newport Beach, California • Vista, California + 12 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Vista", "state": "California" }, { "city": "Aventura", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02135718" }, { "nct_id": "NCT03781596", "title": "EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Eosinophilic Esophagitis" ], "interventions": [ { "name": "Retrospective evaluation of endoscopy prior to study drug", "type": "DIAGNOSTIC_TEST" }, { "name": "Symptom Survey", "type": "OTHER" }, { "name": "Medication Compliance Phone Call", "type": "OTHER" }, { "name": "Endoscopy while on study drug", "type": "DIAGNOSTIC_TEST" }, { "name": "Fluticasone", "type": "DRUG" }, { "name": "Omeprazole", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER", "DRUG" ], "sponsor": "Claire Daniels", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "6 Years to 60 Years" }, "enrollment_count": 100, "start_date": "2018-10-02", "completion_date": "2022-10-02", "has_results": false, "last_update_posted_date": "2018-12-20", "last_synced_at": "2026-09-30T08:03:20.523Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03781596" }, { "nct_id": "NCT00358358", "title": "Chronic Obstructive Pulmonary Disease Endpoints Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Propionate/Salmeterol 500/50mcg combination", "type": "DRUG" }, { "name": "Fluticasone Propionate 500mcg", "type": "DRUG" }, { "name": "Salmeterol 50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 163, "start_date": "2006-03", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2017-01-20", "last_synced_at": "2026-09-30T08:03:20.523Z", "location_count": 4, "location_summary": "Absecon, New Jersey • Charleston, South Carolina • Greenville, South Carolina + 1 more", "locations": [ { "city": "Absecon", "state": "New Jersey" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Greenville", "state": "South Carolina" }, { "city": "Spartanburg", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00358358" }, { "nct_id": "NCT02301975", "title": "An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler", "type": "DRUG" }, { "name": "Placebo inhalation powders via ELLIPTA inhaler", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler", "type": "DRUG" }, { "name": "Placebo inhalation powder via ACCUHALER/DISKUS inhaler", "type": "DRUG" }, { "name": "Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1526, "start_date": "2015-03-01", "completion_date": "2016-11-25", "has_results": true, "last_update_posted_date": "2018-08-06", "last_synced_at": "2026-09-30T08:03:20.523Z", "location_count": 34, "location_summary": "Huntington Beach, California • Riverside, California • Rolling Hills Estates, California + 30 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02301975" }, { "nct_id": "NCT04885530", "title": "ACTIV-6: COVID-19 Study of Repurposed Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Ivermectin", "type": "DRUG" }, { "name": "Fluvoxamine", "type": "DRUG" }, { "name": "Fluticasone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Susanna Naggie, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 10956, "start_date": "2021-06-08", "completion_date": "2024-04-29", "has_results": true, "last_update_posted_date": "2025-11-17", "last_synced_at": "2026-09-30T08:03:20.523Z", "location_count": 110, "location_summary": "Chandler, Arizona • Gilbert, Arizona • Mesa, Arizona + 96 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04885530" }, { "nct_id": "NCT01706328", "title": "A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF/VI 100/25 Inhalation Powder NDPI", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol 250/50 Inhalation Powder ACCUHALER/DISKUS", "type": "DRUG" }, { "name": "Placebo Inhalation Powder NDPI", "type": "DRUG" }, { "name": "Placebo Inhalation Powder ACCUHALER/DISKUS", "type": "DRUG" }, { "name": "Salbutamol as needed", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 828, "start_date": "2012-10-15", "completion_date": "2013-06-17", "has_results": true, "last_update_posted_date": "2018-05-02", "last_synced_at": "2026-09-30T08:03:20.523Z", "location_count": 16, "location_summary": "Clearwater, Florida • DeLand, Florida • Coeur d'Alene, Idaho + 13 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "DeLand", "state": "Florida" }, { "city": "Coeur d'Alene", "state": "Idaho" }, { "city": "Normal", "state": "Illinois" }, { "city": "Woodbury", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01706328" }, { "nct_id": "NCT01313676", "title": "Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "fluticasone furoate/vilanterol", "type": "DRUG" }, { "name": "fluticasone furoate", "type": "DRUG" }, { "name": "vilanterol", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 16568, "start_date": "2011-01-25", "completion_date": "2015-07-15", "has_results": true, "last_update_posted_date": "2018-08-06", "last_synced_at": "2026-09-30T08:03:20.523Z", "location_count": 506, "location_summary": "Andalusia, Alabama • Athens, Alabama • Birmingham, Alabama + 369 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01313676" }, { "nct_id": "NCT00517634", "title": "Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FP", "type": "DRUG" }, { "name": "SFC", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 23, "start_date": "2007-08", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-09-30T08:03:20.523Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00517634" }, { "nct_id": "NCT02980133", "title": "Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Propionate", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 841, "start_date": "2016-12-28", "completion_date": "2019-04-13", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-30T08:03:20.523Z", "location_count": 77, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Bakersfield, California + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Corona", "state": "California" }, { "city": "Downey", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02980133" } ] }